Mehdi Yousefi | Immunology and Microbiology | Best Researcher Award

Published on by Global Scholar Awards

Prof. Mehdi Yousefi | Immunology and Microbiology | Best Researcher Award

Professsor at Tabriz University of Medical Sciences, Iran

Prof. Mehdi Yousefi, Associate Professor of Immunology at Tabriz University of Medical Sciences, is a distinguished researcher with an exceptional track record in immunology, reproductive immunology, autoimmune diseases, and cancer immunotherapy. With over a decade of academic and research experience, Prof. Yousefi has published extensively in high-impact journals, earning a Scopus H-index of 58 and a Google Scholar H-index of 71, placing him among the top 1% of highly cited researchers globally. His innovative contributions include several patents on human antibody fragments and advanced biomedical tools, reflecting his strong focus on translational research. Prof. Yousefi has been recognized multiple times as a Top Researcher by Tabriz University of Medical Sciences and has received the prestigious national Razi Award. Through his leadership, collaborative research, and commitment to advancing immunological science, Prof. Yousefi has made significant contributions to both basic and applied biomedical research, enhancing the scientific community’s understanding of immune-related diseases.

Professional Profile 

Education

Prof. Mehdi Yousefi has a strong and distinguished educational background in medical sciences, particularly in immunology. He earned his Bachelor’s degree (B.Sc.) in Medical Laboratory Technology from Tehran University of Medical Sciences in 2004, where he demonstrated academic excellence. He continued his studies at the same university, completing his Master’s degree (M.Sc.) in Immunology in 2007, where he ranked first in the national entrance exam for the program. Building on his passion for immunological research, Prof. Yousefi pursued a PhD in Immunology, also at Tehran University of Medical Sciences, and graduated in 2013 with the highest possible score (20 out of 20). His PhD research focused on humoral immune responses against tetanus toxin at the single-cell level, showcasing his expertise in immunological techniques and innovative approaches to studying immune mechanisms. His consistent academic excellence, top rankings, and commitment to scientific research laid a strong foundation for his successful career in immunology and medical sciences.

Professional Experience

Prof. Mehdi Yousefi has built an impressive professional career rooted in both academic excellence and cutting-edge research. Since 2013, he has served as an academic and research member at the Department of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences, where he currently holds the position of Associate Professor of Immunology. His professional focus spans a wide range of areas, including reproductive immunology, autoimmune diseases, rheumatic disorders, and cancer immunotherapy. Prof. Yousefi has played a pivotal role in mentoring students, leading collaborative research projects, and contributing to the development of advanced immunological diagnostics and therapies. His innovative work has resulted in numerous patents, particularly in the field of antibody fragment development and cancer targeting, demonstrating his ability to bridge fundamental science with clinical applications. Through his leadership, prolific publications, and active participation in the scientific community, Prof. Yousefi has established himself as a respected and influential figure in immunology research.

Research Interest

Prof. Mehdi Yousefi’s research interests focus on understanding the complex mechanisms of the immune system and its role in health and disease. His primary areas of interest include reproductive immunology, where he investigates the immune system’s involvement in pregnancy complications and maternal-fetal tolerance. He also conducts extensive research on autoimmune diseases and rheumatic disorders, aiming to uncover the immunopathological mechanisms driving these conditions to develop more targeted therapies. In addition, Prof. Yousefi has a strong focus on cancer immunotherapy, particularly the development of novel antibody fragments and immunomodulatory approaches for treating cancers such as breast and colorectal cancer. His work also extends to neurosciences, where he explores the immune system’s interactions with the nervous system in neuroinflammatory and neurodegenerative diseases. Through his multidisciplinary approach, combining basic immunology, translational research, and clinical applications, Prof. Yousefi aims to advance immunological knowledge and develop innovative diagnostic and therapeutic strategies for immune-related disorders.

Award and Honor

Prof. Mehdi Yousefi has received numerous prestigious awards and honors, recognizing his outstanding contributions to immunology and biomedical research. He has been repeatedly honored as the Top Researcher at Tabriz University of Medical Sciences in 2014, 2015, 2017, 2020, and 2021, reflecting his consistent excellence in scientific output and impactful research projects. In 2020, he was further recognized at the national level with the prestigious Razi Award, one of the highest honors for medical research in Iran. In 2022, Prof. Yousefi’s global impact was highlighted when he was named among the Top 1% Highly Cited Researchers (ESI), a distinction that underscores the international significance and influence of his publications. These accolades, combined with his numerous patents and his leadership in innovative research projects, demonstrate Prof. Yousefi’s dedication, creativity, and commitment to advancing immunological science, both within Iran and on the global stage.

Research skill

Prof. Mehdi Yousefi possesses a diverse and advanced set of research skills that have enabled him to excel in the fields of immunology, molecular biology, and translational medicine. His expertise includes designing and conducting immunological assays, such as flow cytometry, ELISA, and cell culture techniques, which he applies to study immune responses in conditions ranging from autoimmune diseases to cancer immunotherapy. He has extensive experience in monoclonal antibody development, including phage display technology for the generation of scFv antibody fragments, which has led to several patents. Prof. Yousefi is also skilled in molecular techniques, such as PCR, gene cloning, and gene expression analysis, which he applies to study immune signaling pathways and immune cell interactions. His collaborative approach, combined with strong project management and scientific writing skills, has resulted in numerous high-impact publications and successful research collaborations, making him a well-rounded and innovative researcher in the field of immunology.

Conclusion

His exceptional publication record, high citation impact, consistent institutional and national awards, and innovative patented research make him a top candidate. His breadth of expertise, from immunology to translational medicine, and his proven track record of impactful research across various fields position him strongly for this recognition

Publications Top Noted

  • The effect of vitamin D supplementation and vaginal probiotics on fertility in women with recurrent implantation failure: A randomized clinical trial
    Authors: Badihi E., Sharifi P., Kamrani A., Aghebati-Maleki L., Yousefi M.
    Journal: Human Immunology
    Year: 2025
    Citations: 0

  • Impact of lymphocyte immunotherapy (LIT) on fertility rates in recurrent pregnancy loss (RPL) women with antinuclear antibodies: A randomized clinical trial
    Authors: Dashti M., Kamrani A., Shahir-Khajeh Z., Mehdizadeh A., Yousefi M.
    Journal: Journal of Reproductive Immunology
    Year: 2025
    Citations: 0

  • Intradermal lymphocyte therapy: A promising treatment for recurrent pregnancy loss in patients without anti-TPO antibodies
    Authors: Ebrahimi R., Asghari K.M., Alamdary S.J., Hojjat-Farsangi M., Yousefi M.
    Journal: Human Immunology
    Year: 2025
    Citations: 0

  • The role of probiotics in restoring the Th1 to Th2 ratio in women experiencing recurrent implantation failure; a double-blind randomized clinical trial
    Authors: Kamrani A., Asghari K.M., Zafarani Y., Zolfaghari M.A., Yousefi M.
    Journal: Human Immunology
    Year: 2025
    Citations: 0

  • Investigating the effect of echinacea extraction syrup on the outcomes of lower respiratory infections in patients with COVID-19: a randomized clinical trial study
    Authors: Kheirandish E., Mahdizadeh M., Mahdizadeh M., Yousefi M., Shojaee S.S.R.
    Journal: Virology Journal
    Year: 2024
    Citations: 0

  • Cyclosporine and fedratinib combination therapy via modulating Th17/Treg balance in Rat model of membranous glomerulonephritis
    Authors: Ghassabi A., Hosseini M., Abdoli Goungormaz H., Etemadi J., Yousefi M.
    Journal: Biochemistry and Biophysics Reports
    Year: 2024
    Citations: 0

  • The sensitivity of acute myeloid leukemia cells to cytarabine is increased by suppressing the expression of Heme oxygenase-1 and hypoxia-inducible factor 1-alpha
    Authors: Sadeghi M., Moslehi A., Kheiry H., Movassaghpuor A.A., Niaragh F.J.
    Journal: Cancer Cell International
    Year: 2024
    Citations: 2

  • Evaluation of changes in exhausted T lymphocytes and miRNAs expression in the different trimesters of pregnancy in pregnant women
    Authors: Shekarchi A.A., Hosseini L., Kamrani A., Ahmadian Heris J., Yousefi M.
    Journal: Molecular Biology Reports
    Year: 2024
    Citations: 0

  • Revolutionized attitude toward recurrent pregnancy loss and recurrent implantation failure based on precision regenerative medicine
    Authors: Asghari K.M., Novinbahador T., Mehdizadeh A., Zolfaghari M.A., Yousefi M.
    Journal: Heliyon
    Year: 2024
    Citations: 0

  • Analysis of Th17 cell population and expression of microRNA and factors related to Th17 in patients with premature ovarian failure
    Authors: Nouri N., Aghebati-Maleki L., Zangbar M.S.S., Chakari-Khiavi F., Yousefi M.
    Journal: Journal of Reproductive Immunology
    Year: 2024
    Citations: 2

Ani Ioana Cotar | Immunology | Best Researcher Award

Published on by Global Scholar Awards

Ani Ioana Cotar | Immunology | Best Researcher Award

PhD, senior researcher at Cantacuzino Research Institute, Romania.

Dr. Ani Ioana Cotar is a distinguished research scientist and head of the National Center for Expertise and Intervention in Public Health for Biological, Chemical, Radiological, and Nuclear Agents at the “Cantacuzino” National Medico-Military Institute in Bucharest, Romania. Her career spans over 20 years, specializing in virology and vector-borne infections, including high-impact diseases such as West Nile, Zika, and Chikungunya viruses. Her expertise in molecular diagnostics and pathogen characterization has positioned her at the forefront of infectious disease research, with extensive experience in immunology and molecular biology techniques. Dr. Cotar’s significant role in global health initiatives is underscored by her work with the EVDLabNet and WHO in external quality assurance (EQA) schemes. Her commitment to advancing public health and her innovative research approaches make her a prominent figure in the field, with her contributions directly impacting diagnostic accuracy and understanding of viral pathogen epidemiology.

Professional Profile

Education

Dr. Cotar’s educational background includes a Ph.D. in Biology from the Faculty of Biology, University of Bucharest, completed in 2009. She holds an MSc in Genetics from the same institution and a BSc in Biology. Additionally, she completed two postdoctoral fellowships; one at the University of Bucharest, where she deepened her understanding of molecular biology, and the other under the European Program for Public Health Microbiology (EUPHEM) in Stockholm. This extensive education laid the groundwork for her career in vector-borne infections and public health. Her advanced studies, particularly in molecular epidemiology, prepared her for her pioneering role in pathogen identification and control. Dr. Cotar’s academic accomplishments highlight her commitment to integrating science with public health practices to improve diagnostic protocols and preventive strategies against infectious diseases.

Professional Experience

Dr. Cotar began her career at the “Cantacuzino” Institute in 2001 as a biologist and progressed to roles of increasing responsibility, becoming a Research Scientist I by 2022 and Head of the National Center in 2023. Her experience includes leading projects on the molecular diagnostics of high-risk vector-borne pathogens and implementing quality assurance testing for the WHO. Her work includes crucial contributions to SARS-CoV-2 diagnostics during the pandemic and coordinating whole-genome sequencing for bacterial pathogens. She has developed protocols for DNA/RNA extraction, PCR, and real-time PCR, bringing rigorous scientific standards to her laboratory’s practices. Her leadership and technical expertise have contributed to significant advancements in Romania’s capacity to detect, monitor, and respond to infectious disease threats, particularly in vector-borne pathogens affecting both national and global health landscapes.

Research Interest

Dr. Cotar’s research interests lie in the molecular epidemiology and diagnostics of viral and bacterial vector-borne pathogens. Her work focuses on identifying and characterizing infectious agents such as West Nile, Zika, and Chikungunya viruses, as well as bacterial pathogens like Rickettsia and Borrelia. She is committed to improving diagnostic capabilities through molecular biology techniques, including PCR, DNA sequencing, and bioinformatics. Dr. Cotar’s research extends to quality assurance, participating in global quality initiatives that enhance laboratory accuracy for pathogen detection. Her expertise in molecular typing and genome sequencing reflects her focus on understanding pathogen transmission, evolution, and resistance, critical for developing effective public health interventions.

Award and Honor

Dr. Cotar has been recognized for her contributions to public health and infectious disease research. Her work on the frontlines of SARS-CoV-2 diagnostics and her efforts to establish protocols for emerging viral and bacterial pathogens have earned her respect within the scientific community. She has received accolades for her role in quality assurance initiatives with the WHO and her contributions to the EVDLabNet. These recognitions underscore her commitment to improving diagnostic accuracy and public health response capabilities, and her dedication has positioned her as an authority in virology and infectious disease research in Romania and beyond.

Conclusion

Dr. Cotar’s deep specialization in vector-borne infectious diseases, coupled with her proven track record in molecular diagnostics and quality assurance, establishes her as a leading candidate for the Best Researcher Award. Her consistent contributions are essential to advancing both national and global health research on infectious diseases.

Publications top noted

Title: Increasing the Awareness of Under-Diagnosed Tropical Cases of Dengue in Romania
Authors: Cismaru, I.M., Radu, M.A., Cotar, A.I., Ghemulet, I., Gheorghita, V.
Year: 2023
Citation: Tropical Medicine and Infectious Disease, 2023, 8(10), 469.

Title: First Detection and Molecular Characterization of Usutu Virus in Culex pipiens Mosquitoes Collected in Romania
Authors: Prioteasa, F.L., Dinu, S., Tiron, G.V., Ceianu, C.S., Cotar, A.I.
Year: 2023
Citation: Microorganisms, 2023, 11(3), 684.

Title: Distribution of Insecticide Resistance Genetic Markers in the West Nile Virus Vector Culex pipiens from South-Eastern Romania
Authors: Stancu, I.G., Prioteasa, F.L., Tiron, G.V., Ceianu, C.S., Csutak, O.
Year: 2022
Citation: Insects, 2022, 13(11), 1062.

Title: Original Contributions to the Chemical Composition, Microbicidal, Virulence-Arresting, and Antibiotic-Enhancing Activity of Essential Oils from Four Coniferous Species
Authors: Visan, D.-C., Oprea, E., Radulescu, V., Chifiriuc, M.C., Marinas, I.C.
Year: 2021
Citation: Pharmaceuticals, 2021, 14(11), 1159.

Title: Characterization and Host-Feeding Patterns of Culex pipiens s.l. Taxa in a West Nile Virus-Endemic Area in Southeastern Romania
Authors: Tiron, G.V., Stancu, I.G., Dinu, S., Ceianu, C.S., Cotar, A.I.
Year: 2021
Citation: Vector-Borne and Zoonotic Diseases, 2021, 21(9), pp. 713–719.

Title: Emergence of Toscana Virus, Romania, 2017-2018
Authors: Popescu, C.P., Cotar, A.I., Dinu, S., Ceianu, C.S., Florescu, S.A.
Year: 2021
Citation: Emerging Infectious Diseases, 2021, 27(5), pp. 1482–1485.

Title: Increased Risk of Chikungunya Infection in Travelers to Thailand During Ongoing Outbreak in Tourist Areas: Cases Imported to Europe and the Middle East, Early 2019
Authors: Javelle, E., Florescu, S.-A., Asgeirsson, H., Hamer, D.H., Gautret, P.
Year: 2019
Citation: Eurosurveillance, 2019, 24(10), 1900146.

Title: West Nile Virus Lineage 2 in Romania, 2015-2016: Co-Circulation and Strain Replacement
Authors: Cotar, A.I., Fǎlcuţǎ, E., Dinu, S., Ceianu, C.S., Prioteasa, F.L.
Year: 2018
Citation: Parasites and Vectors, 2018, 11(1), 562.

Title: Re-Emergence of Severe West Nile Virus Neuroinvasive Disease in Humans in Romania, 2012 to 2017 – Implications for Travel Medicine
Authors: Popescu, C.P., Florescu, S.A., Cotar, A.I., Ceausu, E., Ruta, S.M.
Year: 2018
Citation: Travel Medicine and Infectious Disease, 2018, 22, pp. 30–35.

Title: Lack of Zika Virus Antibody Response in Confirmed Patients in Non-Endemic Countries
Authors: Lustig, Y., Cotar, A.I., Ceianu, C.S., Aarons, E., Reusken, C.
Year: 2018
Citation: Journal of Clinical Virology, 2018, 99-100, pp. 31–34.